Opportunity discovery
Deal intelligence is Tulevik’s target identification and market mapping service for private equity sponsors, strategic acquirers, and corporate development teams pursuing life sciences manufacturing and services assets. Tulevik screens the full universe of candidate facilities against a defined technical specification, profiles the shortlist at asset level, and makes confidential approaches — frequently reaching owners before an asset enters a formal sale process.
By the time an asset is marketed, the advantage is gone
Most life sciences manufacturing assets reach buyers through a banker’s process, on the seller’s timetable, against a field of competing bidders. By then the price reflects the competition rather than the asset.
The alternative requires knowing the universe before anyone is selling: which facilities exist, what they can actually run, who owns them, what has been invested, and which owners are approaching a decision. That knowledge is not purchasable. It is built through asset-level analysis and sustained relationships with operators, and it is what allows a buyer to arrive first and negotiate on merit.
Tulevik builds that picture for each mandate from the ground up, against the buyer’s own technical criteria rather than a generic screen.
What this covers
- Market mapping and landscape intelligence
- Opportunity identification and prioritisation
- Strategic market positioning
- Target identification and engagement
- Valuation and market benchmarking
Once a target is identified, Curated M&A advisory takes it through execution. Where the question is which market to enter rather than which asset to buy, Insight-driven market entry is the starting point.